Drug Safety Strategies for Perioperative Medication Reconciliation and Risk Reduction

Abstract

Ensuring drug safety during the perioperative period is paramount, as medication errors and adverse drug events (ADEs) are significant contributors to patient morbidity and mortality. Perioperative medication reconciliation—systematically reviewing and managing a patient’s medications before, during, and after surgery—is vital for risk reduction. This review synthesizes current evidence on strategies for perioperative medication reconciliation, delineates risk reduction approaches, and discusses guideline-based recommendations to optimize patient safety. The article integrates epidemiological insights, mechanistic considerations, and practical interventions, providing clinicians with actionable knowledge to mitigate perioperative medication risks through structured, multidisciplinary efforts.

Introduction

The perioperative environment is characterized by complex workflows, transitions of care, and the use of multiple pharmacological agents. These factors create a heightened risk for medication discrepancies, omissions, duplications, and inappropriate dosing—each of which can precipitate ADEs. Medication reconciliation serves as a cornerstone for drug safety, aiming to ensure that patients’ medication lists are accurate and complete across all perioperative phases. This article reviews the burden of perioperative medication errors, explores underlying mechanisms, identifies at-risk populations, and presents evidence-based strategies for safe medication practices in perioperative care settings.

Epidemiology / Disease Burden

Medication errors in the perioperative period constitute a major patient safety concern. Studies estimate that up to 50% of surgical patients experience at least one medication discrepancy during hospitalization. The incidence of perioperative ADEs ranges from 5% to 20%, with a higher prevalence in elderly patients and those with polypharmacy. Data from the American Society of Anesthesiologists Closed Claims Project highlight that medication-related events account for approximately 20% of perioperative claims, underscoring the clinical and medico-legal significance of rigorous drug safety strategies.

Pathophysiology

The pathophysiology of perioperative medication errors involves multifaceted factors: altered pharmacokinetics and pharmacodynamics due to surgical stress, anesthesia, and organ dysfunction; the impact of drug-drug interactions; and the effect of incomplete medical histories. Surgical interventions can alter drug absorption, distribution, metabolism, and excretion, necessitating real-time medication adjustments. Inadequate reconciliation may expose patients to risks such as hemodynamic instability, bleeding, infection, and perioperative delirium, emphasizing the need for mechanism-based vigilance.

Risk Factors

Several risk factors increase the likelihood of perioperative medication errors: advanced age, comorbidities (renal or hepatic impairment), polypharmacy, emergency surgeries, language barriers, and care transitions between outpatient, inpatient, and surgical teams. Communication failures, incomplete documentation, and lack of standardized protocols further compound these risks. Patients on high-alert medications (anticoagulants, insulin, immunosuppressants) are particularly vulnerable to adverse outcomes if reconciliation is suboptimal.

Clinical Features

Clinical manifestations of perioperative medication errors are diverse, ranging from mild symptoms (nausea, confusion) to severe complications (arrhythmias, hypotension, hemorrhage, stroke). Unrecognized medication omissions may result in withdrawal syndromes or disease exacerbation, while inappropriate continuation of certain drugs (e.g., antithrombotics, ACE inhibitors) can lead to intraoperative instability. Vigilance for atypical presentations, especially in elderly or cognitively impaired patients, is essential for timely recognition and intervention.

Diagnosis

Diagnosis of perioperative medication discrepancies relies on meticulous chart review, patient interviews, and cross-referencing with pharmacy records. Structured tools such as the Medication Reconciliation Process (MedRec) and electronic health record (EHR)-integrated checklists support systematic identification and resolution of discrepancies. Involving patients, caregivers, and multidisciplinary teams—including pharmacists and anesthesiologists—enhances diagnostic accuracy and continuity of care.

Treatment & Management

Effective management of perioperative medication safety hinges on proactive reconciliation at all transition points: pre-admission, preoperative holding, intraoperative, and postoperative phases. Key steps include compiling a best possible medication history (BPMH), assessing indication and necessity of each drug, identifying potential interactions, and tailoring perioperative regimens. Pharmacist-led interventions, standardized order sets, and communication protocols are proven to reduce errors. Real-time documentation and clear handoffs between teams further mitigate risk. When discrepancies or ADEs are identified, prompt corrective action and supportive care are imperative.

Recent Advances / Emerging Therapies

Recent advances in perioperative medication safety include the integration of clinical decision support systems (CDSS) within EHRs, real-time alerting for drug interactions, and automated medication reconciliation modules. Artificial intelligence (AI) and machine learning algorithms are being piloted to predict high-risk profiles and flag potential errors before they reach the patient. Collaborative care models—such as perioperative medicine services and pharmacist-led reconciliation teams—demonstrate significant reductions in medication discrepancies and postoperative complications in recent studies.

Guideline Recommendations

Leading guidelines, including those from the Joint Commission, Institute for Safe Medication Practices (ISMP), and American Society of Health-System Pharmacists (ASHP), emphasize medication reconciliation as a mandatory safety practice. Key recommendations entail: developing standardized reconciliation processes, ensuring involvement of pharmacists, educating all healthcare providers on drug safety, and utilizing technology for documentation and alerts. Guidelines advocate for clear communication, especially at care transitions, and regular audits to monitor reconciliation effectiveness and adherence.

Conclusion

Perioperative medication reconciliation and risk reduction are integral to patient safety and quality surgical outcomes. Through a combination of systematic reconciliation, interprofessional collaboration, and adherence to evidence-based guidelines, clinicians can significantly reduce the incidence of medication errors and associated morbidity. Ongoing advances in technology and process optimization hold promise for further improvements. Clinicians are encouraged to prioritize and continually refine drug safety strategies as part of comprehensive perioperative care.